Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunologic Research|January 1, 1992
IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosusC E Siegert, M R Daha, S Lobatto, et al.
Clinical and Experimental Rheumatology|January 1, 1992
IgG and IgA autoantibodies to C1q in systemic and renal diseasesC E Siegert, M R Daha, C Halma, et al.
Scandinavian Journal of Immunology|April 1, 1995
Subclass distribution of IgA and IgG antibodies against Clq in patients with rheumatic diseasesI E Coremans, M R Daha, E A van der Voort, et al.
Clinical Immunology and Immunopathology|June 1, 1993
The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosusC E Siegert, M R Daha, A J Swaak, et al.
International Archives of Allergy and Immunology|January 1, 1994
Antiendothelial cell antibodies in systemic lupus erythematosus: enhanced antibody binding to interleukin-1-stimulated endotheliumJ M van der Zee, A M Miltenburg, C E Siegert, et al.
Clinical and Experimental Immunology|May 1, 1991
Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE)J M van der Zee, C E Siegert, T A de Vreede, et al.
Annals of the Rheumatic Diseases|December 1, 1993
Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosusC E Siegert, M R Daha, C M Tseng, et al.
Clinical and Experimental Immunology|March 5, 1998
Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE)R H van den Berg, C E Siegert, M C Faber-Krol, et al.
Clinical Nephrology|March 28, 2001
Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to NeoralY W Sijpkens, M J Mallat, C E Siegert, et al.
Pageof 2